Pharmacokinetics of once-daily dolute-gravir and ritonavir-boosted darunavir in HIV patients: the DUALIS study

被引：10
|
作者：
Spinner, Christoph D. [1 ,2 ]
Kuemmerle, Tim [3 ]
Krznaric, Ivanka [4 ]
Degen, Olaf [5 ]
Schwerdtfeger, Christiane [1 ,2 ]
Zink, Alexander [2 ,6 ]
Wolf, Eva [7 ]
Klinker, Hartwig H. F. [8 ]
Boesecke, Christoph [2 ,9 ]
机构：
[1] Univ Hosp Klinikum Rechts Isar, Dept Med 2, Ismaninger Str 22, D-81675 Munich, Germany
[2] German Ctr Infect Res DZIF, Braunschweig, Germany
[3] Univ Hosp Cologne, Dept Med 1, Kerpenerstr 62, D-50937 Cologne, Germany
[4] Zentrum Infektiol Prenzlauer Berg ZIBP, Driesenerstr 20, D-10439 Berlin, Germany
[5] Univ Klinikum Hamburg Eppendorf, Infect Dis Unit, Martinistr 52, D-20246 Hamburg, Germany
[6] Univ Hosp Klinikum Rechts Isar, Dept Dermatol & Allergol, Ismaninger Str 22, D-81675 Munich, Germany
[7] MUC Res, Karlspl 8, D-80335 Munich, Germany
[8] Univ Wurzburg, Med Ctr, Div Infect Dis, Dept Med 2, Oberduerracherstr 6, D-97080 Wurzburg, Germany
[9] Bonn Univ Hosp, Dept Med 1, Sigmund Freud Str 25, D-53127 Bonn, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2017年 / 72卷 / 09期
关键词：
SIMULTANEOUS QUANTIFICATION; INHIBITOR; PLASMA;
D O I：
10.1093/jac/dkx105
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：2679 / 2681
页数：4
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of boosted once-daily darunavir
    Kakuda, Thomas N.
    Brochot, Anne
    Tomaka, Frank L.
    Vangeneugden, Tony
    Van De Casteele, Tom
    Hoetelmans, Richard M. W.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (10) : 2591 - 2605
  • [2] Efficacy and safety of once-daily ritonavir-boosted darunavir and abacavir/lamivudine for treatment-naive patients: a pilot study
    Nishijima, Takeshi
    Tsukada, Kunihisa
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    [J]. AIDS, 2012, 26 (05) : 649 - 651
  • [3] Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients
    Zucman, David
    De Truchis, P.
    Peytavin, Gilles
    Descamps, Diane
    Duvivier, C.
    Tegna, L.
    Weiss, Laurence
    Delassus, Jean L.
    Benalycherif, A.
    Landman, Roland
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (05) : 407 - 410
  • [4] Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting
    Macias, J.
    Recio, E.
    Marquez, M.
    Garcia, C.
    Jimenez, P.
    Merino, D.
    Munoz, L.
    Pasquau, J.
    Ojeda, G.
    Bancalero, P.
    Chueca, N.
    Pineda, J. A.
    [J]. HIV MEDICINE, 2014, 15 (07) : 417 - 424
  • [5] Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women
    Crauwels, H. M.
    Kakuda, T. N.
    Ryan, B.
    Zorrilla, C.
    Osiyemi, O. O.
    Yasin, S.
    Brown, K.
    Verboven, P.
    Hillewaert, V.
    Baugh, B.
    [J]. HIV MEDICINE, 2016, 17 (09) : 643 - 652
  • [6] Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
    Conradie, F.
    Zorrilla, C.
    Josipovic, D.
    Botes, M.
    Osiyemi, O.
    Vandeloise, E.
    Eley, T.
    Child, M.
    Bertz, R.
    Hu, W.
    Wirtz, V.
    McGrath, D.
    [J]. HIV MEDICINE, 2011, 12 (09) : 570 - 579
  • [7] Ritonavir-Boosted Darunavir Is Rarely Associated with Nephrolithiasis Compared with Ritonavir-Boosted Atazanavir in HIV-Infected Patients
    Nishijima, Takeshi
    Hamada, Yohei
    Watanabe, Koji
    Komatsu, Hirokazu
    Kinai, Ei
    Tsukada, Kunihisa
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Kikuchi, Yoshimi
    Oka, Shinichi
    [J]. PLOS ONE, 2013, 8 (10):
  • [8] Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV
    Tsirizani, Lufina
    Mohsenian Naghani, Shaghayegh
    Waalewijn, Hylke
    Szubert, Alexander
    Mulenga, Veronica
    Chabala, Chishala
    Bwakura-Dangarembizi, Mutsa
    Chitsamatanga, Moses
    Rutebarika, Diana A.
    Musiime, Victor
    Kasozi, Mariam
    Lugemwa, Abbas
    Monkiewicz, Lara N.
    McIlleron, Helen M.
    Burger, David M.
    Gibb, Diana M.
    Denti, Paolo
    Wasmann, Roeland E.
    Colbers, Angela
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024,
  • [9] The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetic profile of once-daily ritonavir-boosted darunavir in HIV-1-infected subjects
    Garvey, L.
    Latch, N.
    Erlwein, O.
    Mohammed, P.
    Mackie, N.
    Walsh, J.
    Scullard, G.
    McClure, M.
    Dickinson, L.
    Back, D.
    Winston, A.
    [J]. HIV MEDICINE, 2010, 11 : 23 - 24
  • [10] Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study
    Weidlich, Simon
    Boesecke, Christoph
    Schneider, Jochen
    Klinker, Hartwig H. F.
    Zink, Alexander
    Balogh, Annamaria
    Wolf, Eva
    Bidner, Helen
    Spinner, Christoph D.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (10) : 3082 - 3084
12345